Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

Huayunuo approval positions China at forefront of viral hepatitis innovation, says GlobalData

Huahui Health has recently secured conditional approval from China’s National Medical Products Administration (NMPA) for Huayunuo (Libevitug Injection), marking it as the first domestically developed monoclonal antibody (mAb) drug for chronic hepatitis D virus (HDV) infection in adults with or without compensated cirrhosis. This move not only addresses a critical treatment gap but also signals China’s […]
Read more

FDA reversal on Moderna’s mRNA-1010 can transform the seasonal influenza vaccines market, says GlobalData

The US Food and Drug Administration’s (FDA) decision to review Moderna’s mRNA-1010, with a Prescription Drug User Fee Act (PDUFA) date set for 05 August 2026, signals a pivotal inflection point for the seasonal influenza vaccines market. If approved, the candidate will introduce the first mRNA-based flu vaccine, potentially redefining production timelines, strain matching precision, […]
Read more

Agentic AI holds key to LLM profitability as enterprise token surge reshapes AI economics, says GlobalData

Agentic AI, not consumer chatbots, will determine whether trillion-dollar investments in large language models (LLMs) ever translate into sustainable profits. As enterprise deployments trigger a surge in application programming interface (API) calls and token consumption, energy intensity and infrastructure economics emerge as decisive variables, reshaping competitive dynamics and defining which players capture value in the […]
Read more

Global deal activity starts on weak note in 2026, says GlobalData

Global deal activity fell sharply year-on-year (YoY) in January 2026, underscoring a broad-based slowdown in risk appetite across markets. The broad-based contraction points to a structural reset in capital allocation priorities, as investors pivot from aggressive expansion to capital preservation, pricing discipline, and execution certainty amid persistent macro and geopolitical volatility, reveals GlobalData, a leading […]
Read more

Soccer dominates EMEA gambling and betting sponsorship in 2025 with over $764 million, reveals GlobalData

EMEA gambling and betting sponsorship is heavily focused on soccer, driven by its unparalleled scale and consistent exposure, making it the top choice for brand visibility and customer reach. With $764.45 million in value, it eclipsed all other listed sports many times in 2025, reveals GlobalData, a leading intelligence and productivity platform. GlobalData’s report, “Sponsorship […]
Read more

Systemic lupus erythematosus and lupus nephritis market to reach $5.9 billion in 7MM by 2034, forecasts GlobalData

The systemic lupus erythematosus (SLE) and lupus nephritis (LN) market across the seven major markets (7MM*) is forecast to grow from $2.4 billion in 2024 to $5.9 billion in 2034, at a compound annual growth rate (CAGR) of 9.6%, according to GlobalData, a leading intelligence and productivity platform. GlobalData’s latest report, “Systemic Lupus Erythematosus and […]
Read more

Australia diagnostic imaging market to grow at 5% CAGR through 2036, forecasts GlobalData

Australia’s diagnostic imaging market is steadily advancing, supported by the measured adoption of software-driven and precision-focused medical devices. As healthcare providers prioritize efficiency, functional assessment, and improved clinical decision-making, imaging technologies are becoming increasingly central to care delivery. Against this backdrop, Australia’s diagnostic imaging market is projected to grow at a compound annual growth rate […]
Read more

Global pain market presents significant opportunities for novel mechanisms and modalities, says GlobalData

There is a lack of diversity within the current pain market, with non-steroidal anti-inflammatory drugs (NSAIDs) and opioids dominating the market. With 98% of currently marketed drugs for pain being generics, the pain market provides significant opportunities for innovation and development, according to GlobalData, a leading intelligence and productivity platform. GlobalData’s latest report, “Global Pain […]
Read more

Supply-side risks to critical minerals endanger technologies across sectors, says GlobalData

The global transition to clean energy is gaining momentum, heavily relying on renewable technologies such as solar PV cells and wind turbines, as well as energy transition solutions like hydrogen, energy storage, and carbon capture. Simultaneously, the technology sector demands materials with exceptional electrical, optical, and thermal properties, while the defense sector increasingly relies on […]
Read more

India’s crude oil import recalibration underscores long-term energy security pivot, says GlobalData

India’s crude diversification marks a structural shift from opportunistic discount buying to disciplined geopolitical risk management. With oil accounting for roughly a quarter of primary energy consumption and import dependence near 87% in 2024, prioritizing compliance resilience, supply optionality, and stronger US linkages signal a more strategic energy security doctrine, according to GlobalData, a leading […]
Read more

1.5T MRI systems market in India to grow at 11% CAGR through 2036, forecasts GlobalData

India’s 1.5T magnetic resonance imaging (MRI) systems market is witnessing notable momentum as healthcare providers seek to enhance diagnostic precision, improve workflow efficiency, and expand access to high-quality imaging services across urban and regional centres. Against this backdrop, the India 1.5T MRI systems market is anticipated to grow at a compound annual growth rate (CAGR) […]
Read more

Aromatherapy air fresheners gain popularity as consumers seek wellness aspects in household products, says GlobalData

Consumers are increasingly seeking wellbeing attributes in household products due to rising concerns about health and mental wellness. This trend is also evident in air fresheners, where consumers are looking for wellness and functional aspects. As a result, aromatherapy-based air fresheners are gaining immense popularity and transforming health-conscious offerings. This is substantiated by a 2025 […]
Read more

Qatar Airways YouTube ads leverage Starlink connectivity and Formula 1 associations to reinforce premium appeal, reveals GlobalData

Qatar Airways’ YouTube advertising campaigns during November 2025 to January 2026 highlight a strategic shift from conventional destination-led advertising to experience-led brand building, where technology, storytelling, and prestige partnerships converge to reinforce premium positioning. By integrating Starlink-powered connectivity and high-profile associations such as Formula 1, the airline is redefining the inflight value proposition, reveals the […]
Read more

China’s new pricing guidelines to push automakers toward innovation-led competition, says GlobalData

China has recently issued new nationwide rules to regulate pricing in the auto industry and curb irregular practices, aiming to restore fair competition and support sustainable market development. The State Administration for Market Regulation’s (SAMR) guidelines set clearer boundaries for lawful pricing by automakers and dealers, require transparent price marking and promotions, and call for […]
Read more

Tissue engineered skin substitutes market in India set for 10% CAGR through 2036, forecasts GlobalData

India’s tissue-engineered skin substitutes market is witnessing growth as demand for advanced wound healing products increases to address chronic and complex wounds, burns, and ulcer care. Against this backdrop, the Indian market is projected to expand at a compound annual growth rate (CAGR) of around 10% through 2036, according to GlobalData, a leading intelligence and […]
Read more
1 … 32 33 34 35 36 … 784